Teleflex (NYSE:TFX – Get Free Report) released its earnings results on Thursday. The medical technology company reported $3.42 EPS for the quarter, topping analysts’ consensus estimates of $3.33 by $0.09, Briefing.com reports. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. The company had revenue of $749.70 million for the quarter, compared to the consensus estimate of $762.98 million. During the same quarter last year, the business posted $3.41 EPS. Teleflex’s quarterly revenue was up .9% compared to the same quarter last year. Teleflex updated its FY24 guidance to $13.80-14.20 EPS and its FY 2024 guidance to 13.800-14.200 EPS.
Teleflex Price Performance
Teleflex stock traded up $1.18 during trading hours on Friday, hitting $237.13. 745,171 shares of the company traded hands, compared to its average volume of 392,632. Teleflex has a 1-year low of $177.63 and a 1-year high of $257.85. The firm has a market cap of $11.17 billion, a P/E ratio of 38.06, a P/E/G ratio of 2.26 and a beta of 1.13. The firm’s 50-day simple moving average is $214.14 and its two-hundred day simple moving average is $221.29. The company has a quick ratio of 1.41, a current ratio of 2.58 and a debt-to-equity ratio of 0.36.
Teleflex Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 16th. Investors of record on Thursday, August 15th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date of this dividend is Thursday, August 15th. Teleflex’s dividend payout ratio is currently 21.83%.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Analysis on Teleflex
Teleflex Company Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Further Reading
- Five stocks we like better than Teleflex
- How to Calculate Stock Profit
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- Buy P&G Now, Before It Sets A New All-Time High
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.